BridgeBio Pharma, Inc. (BBIO): SCHEDULE 13D/A filed Jul 10, 2026

Form type

SCHEDULE 13D/A

Filing date

Jul 10, 2026

Accession number

0000905148-26-003237

Filer

BridgeBio Pharma, Inc. (CIK 1743881)